CAS 857402-63-2 appears in our catalog under these names: Retaspimycin Hydrochloride, IPI–504 (Retaspimycin hydrochloride), Retaspimycin (Hydrochloride), 96.16%, Retaspimycin Hydrochloride, 95.77%. Offered by: TargetMol, GLPBio, MedChemExpress, Chemat. Available pack sizes: 2mg, 5mg, 10mg, 50mg, 100mg, 10mM (in 1ml dmso), 5 mg, 100 mg.
Retaspimycin hydrochloride is a hydrochloride that is the monohydrochloride salt of retaspimycin. A semi-synthetic water-soluble analogue of geldanamycin used in cancer treatment. It has a role as an antineoplastic agent and a Hsp90 inhibitor. It contains a retaspimycin(1+).
Source: ChEBI
| Molecular formula | C31H46ClN3O8 |
|---|---|
| Molecular weight | 624.2 g/mol |
| IUPAC name | [(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13,20,22-trihydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3-oxo-19-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18(22),19-hexaen-9-yl] carbamate;hydrochloride |
| InChIKey | OIRUWDYJGMHDHJ-AFXVCOSJSA-N |
| SMILES | C[C@H]1C[C@@H]([C@@H]([C@H](/C=C(/[C@@H]([C@H](/C=C\C=C(\C(=O)NC2=CC(=C(C(=C2O)C1)NCC=C)O)/C)OC)OC(=O)N)\C)C)O)OC.Cl |
Computed by PubChem (NCBI)